 |
Regulator recommends dapagliflozin in triple therapy Related items from OnMedica Glycosylated haemoglobin (HbA1c) and screening for diabetes Diabetes drugs costs NHS England nearly £1bn a year Intensive treatment of type 2 diabetes with microalbuminuria reaps benefits NICE guidance delays hinder good diabetes care Diabetes prescriptions rise by a third in last five years |
Thursday, 24 November 2016
NICE approves extra ‘triple therapy’ drug for diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment